7.80
0.50 (6.85%)
| Penutupan Terdahulu | 7.30 |
| Buka | 7.80 |
| Jumlah Dagangan | 3,160 |
| Purata Dagangan (3B) | 28,915 |
| Modal Pasaran | 9,602,214 |
| Harga / Jualan (P/S) | 164.31 |
| Harga / Buku (P/B) | 1.11 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 1 Sep 2025 |
| Margin Keuntungan | 3,521.74% |
| Margin Operasi (TTM) | -853.23% |
| EPS Cair (TTM) | -7.46 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -69.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.49% |
| Nisbah Semasa (MRQ) | 3.03 |
| Aliran Tunai Operasi (OCF TTM) | -3.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.57 M |
| Pulangan Atas Aset (ROA TTM) | -25.09% |
| Pulangan Atas Ekuiti (ROE TTM) | -163.15% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Addex Therapeutics Ltd | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.33 |
|
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Institusi | 1.13% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |